PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NVS vs. PG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


NVSPG
YTD Return-0.13%12.80%
1Y Return3.93%6.90%
3Y Return (Ann)10.98%9.67%
5Y Return (Ann)9.02%11.88%
10Y Return (Ann)6.96%10.25%
Sharpe Ratio0.230.50
Daily Std Dev17.02%14.09%
Max Drawdown-41.72%-54.23%
Current Drawdown-7.03%0.00%

Fundamentals


NVSPG
Market Cap$200.10B$380.67B
EPS$4.40$6.11
PE Ratio22.1526.40
PEG Ratio5.093.28
Revenue (TTM)$47.73B$84.06B
Gross Profit (TTM)$36.74B$39.25B
EBITDA (TTM)$18.94B$24.22B

Correlation

-0.50.00.51.00.3

The correlation between NVS and PG is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

NVS vs. PG - Performance Comparison

In the year-to-date period, NVS achieves a -0.13% return, which is significantly lower than PG's 12.80% return. Over the past 10 years, NVS has underperformed PG with an annualized return of 6.96%, while PG has yielded a comparatively higher 10.25% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


600.00%650.00%700.00%750.00%800.00%850.00%NovemberDecember2024FebruaryMarchApril
641.95%
844.29%
NVS
PG

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Novartis AG

The Procter & Gamble Company

Risk-Adjusted Performance

NVS vs. PG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and The Procter & Gamble Company (PG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NVS
Sharpe ratio
The chart of Sharpe ratio for NVS, currently valued at 0.23, compared to the broader market-2.00-1.000.001.002.003.000.23
Sortino ratio
The chart of Sortino ratio for NVS, currently valued at 0.45, compared to the broader market-4.00-2.000.002.004.006.000.45
Omega ratio
The chart of Omega ratio for NVS, currently valued at 1.05, compared to the broader market0.501.001.501.05
Calmar ratio
The chart of Calmar ratio for NVS, currently valued at 0.34, compared to the broader market0.002.004.006.000.34
Martin ratio
The chart of Martin ratio for NVS, currently valued at 0.79, compared to the broader market-10.000.0010.0020.0030.000.79
PG
Sharpe ratio
The chart of Sharpe ratio for PG, currently valued at 0.50, compared to the broader market-2.00-1.000.001.002.003.000.50
Sortino ratio
The chart of Sortino ratio for PG, currently valued at 0.80, compared to the broader market-4.00-2.000.002.004.006.000.80
Omega ratio
The chart of Omega ratio for PG, currently valued at 1.10, compared to the broader market0.501.001.501.10
Calmar ratio
The chart of Calmar ratio for PG, currently valued at 0.67, compared to the broader market0.002.004.006.000.67
Martin ratio
The chart of Martin ratio for PG, currently valued at 1.72, compared to the broader market-10.000.0010.0020.0030.001.72

NVS vs. PG - Sharpe Ratio Comparison

The current NVS Sharpe Ratio is 0.23, which is lower than the PG Sharpe Ratio of 0.50. The chart below compares the 12-month rolling Sharpe Ratio of NVS and PG.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00NovemberDecember2024FebruaryMarchApril
0.23
0.50
NVS
PG

Dividends

NVS vs. PG - Dividend Comparison

NVS's dividend yield for the trailing twelve months is around 3.89%, more than PG's 2.35% yield.


TTM20232022202120202019201820172016201520142013
NVS
Novartis AG
3.89%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%3.37%
PG
The Procter & Gamble Company
2.35%2.55%2.38%2.08%2.24%2.37%3.09%2.98%3.18%3.31%2.78%2.91%

Drawdowns

NVS vs. PG - Drawdown Comparison

The maximum NVS drawdown since its inception was -41.72%, smaller than the maximum PG drawdown of -54.23%. Use the drawdown chart below to compare losses from any high point for NVS and PG. For additional features, visit the drawdowns tool.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%NovemberDecember2024FebruaryMarchApril
-7.03%
0
NVS
PG

Volatility

NVS vs. PG - Volatility Comparison

Novartis AG (NVS) has a higher volatility of 5.67% compared to The Procter & Gamble Company (PG) at 4.01%. This indicates that NVS's price experiences larger fluctuations and is considered to be riskier than PG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%NovemberDecember2024FebruaryMarchApril
5.67%
4.01%
NVS
PG

Financials

NVS vs. PG - Financials Comparison

This section allows you to compare key financial metrics between Novartis AG and The Procter & Gamble Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items